Nicole R. Leboeuf
Expertise in
19
conditions

Dr. Nicole R. Leboeuf

Dermatology
Dana-Farber Cancer Institute, Center For Cutaneous Oncology
450 Brookline Avenue, 
Boston, MA 
Accepting New Patients
Offers Telehealth
Expertise in
19
conditions
Dana-Farber Cancer Institute, Center For Cutaneous Oncology
450 Brookline Avenue, 
Boston, MA 

Overview

Nicole Leboeuf is a Dermatologist practicing medicine in Boston, Massachusetts.

Dr. Leboeuf is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Dr. Leboeuf is board certified in Dermatology. She is actively involved in clinical research, co-authoring 183 peer reviewed articles and participating in 3 clinical trials. Dr. Leboeuf is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in TX

Board Certifications

Dermatology

Fellowships

Brigham and Women's Hospital, 2010 - 2011

Hospital Affiliations

Brigham And Women's Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Dana-Farber Cancer Institute, Center for Cutaneous Oncology
450 Brookline Avenue, Boston, MA 02115
Other Locations
Brigham and Women's Fish Center for Women's Health
850 Boylston Street, Suite 402 Mass General Brigham Healthcare Center, Chestnut Hill, MA 02467

Additional Areas of Focus

Dr. Leboeuf has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Study of Talimogene Laherparepvec Followed by Talimogene Laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Other Rare Skin Tumors
A Phase II Study of Talimogene Laherparepvec Followed by Talimogene Laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Other Rare Skin Tumors
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2026
Intervention Type: Biological, Procedure, Other
Study Drugs: Nivolumab, Talimogene Laherparevec
Study Phase: Phase 2
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Enrollment Status: Unknown
Publish Date: March 04, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Randomized Double-Blind Trial of Topical Tazarotene 0.1% Gel Versus Placebo Gel for the Prevention of Regorafenib-Induced Hand-Foot-Skin Reaction
A Phase II Randomized Double-Blind Trial of Topical Tazarotene 0.1% Gel Versus Placebo Gel for the Prevention of Regorafenib-Induced Hand-Foot-Skin Reaction
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Other
Study Phase: Phase 2
View 2 Less Clinical Trials

183 Total Publications

Comparison of Pleomorphic Dermal Sarcoma to Advanced Cutaneous Squamous Cell Carcinoma and Soft-Tissue Sarcoma.
Comparison of Pleomorphic Dermal Sarcoma to Advanced Cutaneous Squamous Cell Carcinoma and Soft-Tissue Sarcoma.
Journal: JAMA dermatology
Published: September 02, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

Brigham And Women's Hospital

221 Longwood Ave, 
Boston, MA 
 (0.3 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Merola is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Merola is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Psoriasis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Plaque Psoriasis. Dr. Merola is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

Brigham Dermatology Associates

221 Longwood Avenue 1st Floor Brigham And Women's At 221 Longwood Boston, 1st Floor Brigham And Women's At 221 Longwood, 
Boston, MA 
 (0.1 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arash Mostaghimi is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Mostaghimi is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Alopecia Areata, Autosomal Recessive Hypotrichosis, Pyoderma Gangrenosum, and Cellulitis. Dr. Mostaghimi is board certified in Dermatology, Clinical Informatics, and Internal Medicine.

Expertise in
25
conditions
Expertise in
25
conditions
Referral required
Before you request

Brigham Dermatology Associates At Brigham And Womens Hospital

221 Longwood Avenue, 
Boston, MA 
 (0.3 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ruth Vleugels is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Vleugels is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Eosinophilic Fasciitis, Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE). Dr. Vleugels is board certified in Dermatology, 2008. Dr. Vleugels is currently accepting new patients.

Frequently Asked Questions about Dr. Nicole R. Leboeuf

How do I make an appointment with Dr. Nicole R. Leboeuf?

You can book an appointment with Dr. Nicole R. Leboeuf by calling their office at 617-632-6571. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nicole R. Leboeuf a top-rated expert for Cutaneous T-Cell Lymphoma (CTCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nicole R. Leboeuf is classified as an Elite expert for Cutaneous T-Cell Lymphoma (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nicole R. Leboeuf specialize in?

While Dr. Nicole R. Leboeuf is a Dermatology, they have specific expertise in Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Mycosis Fungoides. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Nicole R. Leboeuf participate in research or clinical trials?

Yes. Dr. Nicole R. Leboeuf has published 183 articles and abstracts on conditions like Cutaneous T-Cell Lymphoma (CTCL). You can view a list of Dr. Nicole R. Leboeuf's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nicole R. Leboeuf accept my insurance?

Dr. Nicole R. Leboeuf accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-632-6571 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leboeuf's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 10 Advanced Conditions
View All 54 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile